Livero Inc.
9245.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | ¥4 | ¥3 | ¥3 | ¥2 |
| % Growth | 23.7% | 13.5% | 7.5% | – |
| Cost of Goods Sold | ¥1 | ¥0 | ¥0 | ¥0 |
| Gross Profit | ¥3 | ¥2 | ¥2 | ¥2 |
| % Margin | 79.6% | 84.8% | 87.1% | 86.3% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥2 | ¥2 | ¥0 |
| SG&A Expenses | ¥2 | ¥2 | ¥2 | ¥2 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | -¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥2 | ¥2 | ¥2 | ¥2 |
| Operating Income | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 12.7% | 6.1% | 3% | 15.1% |
| Other Income/Exp. Net | ¥0 | -¥0 | ¥0 | -¥0 |
| Pre-Tax Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Net Income | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 9.4% | 3.6% | 2% | 10.1% |
| EPS | 64.6 | 19.85 | 9.57 | 48.66 |
| % Growth | 225.4% | 107.4% | -80.3% | – |
| EPS Diluted | 59.14 | 18.44 | 8.74 | 43.03 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥1 | ¥0 | ¥0 | ¥0 |
| % Margin | 14.9% | 6.1% | 4.4% | 16% |